EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ACE1 does not influence cerebral Aβ degradation or amyloid plaque accumulation in 5XFAD mice

Sohee Jeon, Alia O Alia iD, Jelena Popovic, Robert Vassar, Leah K Cuddy iD

PLOS One · 15.09.2025 · 20 (9) · e0330193

DOI: 10.1371/journal.pone.0330193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 15.09.2025. Verfasst von Sohee Jeon und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America. Hauptthemen laut MEDLINE: Plaque, Amyloid, Amyloid beta-Peptides, Alzheimer Disease, Peptidyl-Dipeptidase A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease is the most common form of dementia, and multiple lines of evidence support the relevance of Aβ deposition and amyloid plaque accumulation in the neurotoxicity and cognitive decline in AD. Rare mutations in angiotensin-converting-enzyme-1 have been highly associated with late onset AD patients; however, the mechanism for ACE1 mutation in AD pathogenesis is unknown. While numerous studies have shown that ACE1 indeed catabolizes Aβ, majority of these studies were performed in vitro, and conflicting results have been reported in clinical and in vivo systems. Therefore, we further investigated this in vivo by generating and examining a novel mouse model. Specifically, we analyzed 6-month-old 5XFAD mice with ACE1 knockdown restricted to excitatory neurons, achieved by driving Cre recombinase expression under the CamKIIα promoter. These mice were generated by crossing 5XFAD mice to ACE1 conditional knockout mice expressing Cre specifically in excitatory neurons. Our analyses revealed that neuronal ACE1 knockdown does not significantly affect amyloid plaque load and neuroinflammation in the hippocampus and cortex of 5XFAD mice at 6-months of age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AmyloidAmyloid beta-PeptidesAlzheimer DiseasePeptidyl-Dipeptidase ACerebral CortexAnimalsMiceDisease Models, AnimalMice, TransgenicMice, KnockoutNeuronsHippocampusHumans

Substanzen

Amyloid beta-PeptidesPeptidyl-Dipeptidase A

Autor:innen und Institutionen

  • The Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
  • Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

ORCID-Profile: Alia O Alia, Leah K Cuddy

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Jeon, S., Alia, A. O., Popovic, J., Vassar, R., & Cuddy, L. K. (2025). ACE1 does not influence cerebral Aβ degradation or amyloid plaque accumulation in 5XFAD mice. PLOS One, 20(9), e0330193. https://doi.org/10.1371/journal.pone.0330193

Vancouver

Jeon S, Alia AO, Popovic J, Vassar R, Cuddy LK. ACE1 does not influence cerebral Aβ degradation or amyloid plaque accumulation in 5XFAD mice. PLOS One. 2025;20(9):e0330193. doi:10.1371/journal.pone.0330193

BibTeX
@article{Jeon2025,
  author = {Jeon, Sohee and Alia, Alia O and Popovic, Jelena and Vassar, Robert and Cuddy, Leah K},
  title = {ACE1 does not influence cerebral Aβ degradation or amyloid plaque accumulation in 5XFAD mice},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {9},
  pages = {e0330193},
  doi = {10.1371/journal.pone.0330193}
}
Kostenlos starten →